Xingbao International Co Ltd operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xingbao International Co Ltd with three other
drug stores in Asia:
FCW Holdings Berhad
sales of 26.57 million Malaysian Ringgits [US$6.69 million]
of which 100%
Muller and Phipps (Ceylon) Plc
of Sri Lanka
(903.25 million Sri Lanka Rupees [US$5.87 million]
Immuno-Biological Laboratories Company Limited
based in Japan
(717.66 million Japanese Yen [US$6.47 million]
of which 73%
was Diagnosis & Reagent).
Xingbao International Co Ltd reported sales of 178.58 million Taiwanese Dollars (US$6.03 million)
December of 2016.
decrease of 27.1%
versus 2015, when the company's sales were 244.93 million Taiwanese Dollars.